Chris Murphy and colleagues defend the competition benefits of a noncompete ban

Chris MurphyU.S. senator from Connecticut, joining a congressional letter

Chris Murphy and colleagues argued that a federal noncompete ban would improve competition after the administration stopped defending the FTC rule.

“A ban on non-compete clauses would increase competition for existing businesses”

Official statement

Read the official statement (opens in a new tab)Murphy and colleagues seek a renewed federal noncompete ban · Chris MurphyJoint letter reproduced in full, opening and closing paragraphs
The Federal Trade Commission headquarters building in Washington, D.C.
Credit: Gunnar Klack / CC BY-SA 4.0

Where this statement fits

Lina Khan defends the FTC's noncompete ban; Andrew Ferguson challenges its authority

The FTC adopted a nationwide noncompete rule in April 2024. Lina Khan defended its benefits and the agency's legal authority. Andrew N. Ferguson argued that Congress had not authorized the rule, regardless of its policy merits. A court blocked enforcement, and the FTC later took steps to dismiss its appeals. The rule is not in effect or enforceable.

Read the full case

Case updates

Want the next important update?

Follow this case and get an email when an important development changes the record.

Important updates only. Free. Confirm your email to start. Unsubscribe anytime. How we handle your email.

Source and context

Official statement

Murphy and colleagues seek a renewed federal noncompete ban (opens in a new tab) · Chris MurphyJoint letter reproduced in full, opening and closing paragraphs

About this source

Senate release and joint letter criticizing the withdrawal of the noncompete appeals and urging legislation.

Archived copy (opens in a new tab)

Before the quotation

The joint letter responded to withdrawal of the noncompete appeals. It argued that case-by-case enforcement would be insufficient for workers bound by noncompetes.

After the quotation

The letter cited projected savings in health care and argued that a ban would let physicians start new practices in their communities.

How this statement is classified

Defended or excused

The label describes this statement's response within the context above.

Why this label?

Relative to the nationwide noncompete ban at issue, Murphy defends the policy by arguing that it would improve competition. The letter urges legislation to secure that protection.

Recorded on
Published here
People and groups discussed
Federal Trade Commission

More from this case

Read the full case

Share or embed this statement

Quote card: Chris Murphy, Chris Murphy and colleagues defend the competition benefits of a noncompete banDownload image (PNG)

The embed keeps its attribution link to The Dispute Index. Credit the image to The Dispute Index and link to the statement page.

Cite this record

Publisher
The Dispute Index
Title
Chris Murphy and colleagues defend the competition benefits of a noncompete ban
First published
Last updated
Permalink
https://disputeindex.com/events/5836-chris-murphy-and-colleagues-argued-that-a-federal

Last updated marks the most recent saved version of this published statement.

The Dispute Index. "Chris Murphy and colleagues defend the competition benefits of a noncompete ban". First published: 2026-10-16. Last updated: 2026-10-16. https://disputeindex.com/events/5836-chris-murphy-and-colleagues-argued-that-a-federal